Abd El-Fadeal, N., Sabek, N., Ismail, E., El-Abaseri, T. (2023). Medium from Umbilical Cord Blood Derived-Hepatoblasts Attenuates Liver Fibrosis in Rats. Suez Canal University Medical Journal, 26(5), 0-0. doi: 10.21608/scumj.2023.306823
Noha M. Abd El-Fadeal; Nagwan A. Sabek; Emad F. Ismail; Taghrid B. El-Abaseri. "Medium from Umbilical Cord Blood Derived-Hepatoblasts Attenuates Liver Fibrosis in Rats". Suez Canal University Medical Journal, 26, 5, 2023, 0-0. doi: 10.21608/scumj.2023.306823
Abd El-Fadeal, N., Sabek, N., Ismail, E., El-Abaseri, T. (2023). 'Medium from Umbilical Cord Blood Derived-Hepatoblasts Attenuates Liver Fibrosis in Rats', Suez Canal University Medical Journal, 26(5), pp. 0-0. doi: 10.21608/scumj.2023.306823
Abd El-Fadeal, N., Sabek, N., Ismail, E., El-Abaseri, T. Medium from Umbilical Cord Blood Derived-Hepatoblasts Attenuates Liver Fibrosis in Rats. Suez Canal University Medical Journal, 2023; 26(5): 0-0. doi: 10.21608/scumj.2023.306823
Medium from Umbilical Cord Blood Derived-Hepatoblasts Attenuates Liver Fibrosis in Rats
Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Suez Canal University, Egypt
Abstract
Background: The liver is a multifunctional organ in our body. Hepatocyte dysfunction may lead to liver failure. Stem cell (SCs) based therapy is a promising technique for the treatment of liver diseases. Umbilical cord-derived mesenchymal stem cells (UCMSCs) are potentially favorable SCs sources for liver transplantation. Aim: We aimed to investigate the in vivo effectiveness of a medium of transdifferentiated hepatoblasts derived from UCMSCs in regenerating liver fibrosis in a rat model. Methods: UCBMSCs were cultured, and expression of specific CD markers was measured by flow cytometer. They were induced to transdifferentiate under pro-hepatogenic conditions, using mainly hepatic growth factor (HGF) and fibroblastic growth factor. Using RT-PCR, the expression of hepatocyte-specific genes was evaluated. A medium of transdifferentiated hepatoblasts was injected in a rat model of CCL4 liver fibrosis followed by an assessment of macroscopic, microscopic, and serum biochemical markers of liver regeneration. Results: After 21 days in culture, UCMSCs adopted the hepatoblasts phenotype. The expression of alpha-fetoprotein (AFP), albumin (ALB), cytokeratin-18 (CK-18), and glucose-6 phosphatase (G6P) significantly increased in differentiated UCMSCs compared to control cells (P < 0.05). In addition, ALB and AFP levels showed a three-fold increase in the medium of differentiated hepatoblasts. The in vivo effectiveness of the medium of transdifferentiated hepatoblasts derived from UCMSCs was assessed following 4 s.c. injections in CCL4 rats, livers showed reduced fibrosis and enhanced biochemical function compared to both sham and diseased groups. Conclusion: Medium from transdifferentiated hepatoblasts obtained from UCMSCs may be an effective and applicable treatment of liver fibrosis in rats with a potential clinical assessment in human liver diseases.
View on SCiNiTO
Top